# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Hepatitis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 101-110 of 500 results.
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
Status: Recruiting
Last Changed: Apr 29, 2020
First Received: Nov 14, 2018
Disease(s): Hepatitis C
Locations: Dong-A University Hospital /ID# 209450, Busan, Busan Gwang Yeogsi, Korea, Republic of
Pusan National University Hosp /ID# 209813, Busan, Busan Gwang Yeogsi, Korea, Republic of
Soon Chun Hyang University Cheonan Hospital /ID# 209996, Cheonan, Chungcheongnamdo, Korea, Republic of
Kyungpook National Univ Hosp /ID# 209294, Daegu, Daegu Gwang Yeogsi, Korea, Republic of
Yeungnam University Med Ctr /ID# 209293, Daegu, Daegu Gwang Yeogsi, Korea, Republic of
... and 57 other locations.
The HOPE Study: Characterizing Patients With Hepatitis B and C
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Dec 16, 2016
Disease(s): Hepatitis B, Chronic, Hepatitis C
Intervention(s): Blood draws, Tenofovir Alafenamide, Knowledge Index Questionnaire, Liver transient elastography (FibroScan), Liver Biopsy
Locations: Unity Health Care, Inc./Walker Jones, Washington, District of Columbia, United States
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States
Pan Asian Volunteer Health Clinic at the Chinese Culture and Community Service Center, Gaithersburg, Maryland, United States
Dr Sang V Tran Internal Medicine Practice, Falls Church, Virginia, United States
A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection
Status: Not yet recruiting
Last Changed: Oct 14, 2020
First Received: Oct 14, 2020
Disease(s): Hepatitis B
Intervention(s): JNJ-73763989, JNJ-56136379, Entecavir (ETV), Tenofovir disoproxil, Tenofovir alafenamide (TAF)
Locations: Johns Hopkins University, Baltimore, Maryland, United States
UZ Antwerpen, Edegem, Belgium
Toronto General Hospital, Toronto, Canada
Hôpital Beaujon, Clichy, France
University Medical Center, Hamburg, Germany
... and 5 other locations.
Stopping Antiviral Treatment in Chronic Hepatitis B
Status: Not yet recruiting
Last Changed: Jun 16, 2020
First Received: Jun 16, 2020
Disease(s): Chronic Hepatitis b
Intervention(s): Entecavir
Locations: Man Fung Yuen, Hong Kong, Please Select One ..., Hong Kong
Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B
Status: Recruiting
Last Changed: Nov 24, 2020
First Received: Jul 02, 2018
Disease(s): Chronic Hepatitis B
Intervention(s): hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN)
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue
Status: Not yet recruiting
Last Changed: Aug 03, 2020
First Received: Aug 03, 2020
Disease(s): Chronic Hepatitis b, Hepatitis B Reactivation
Intervention(s): Vemlidy
Locations: Buddhist Tzu Chi General Hospital, Da-Lin Branch, Chiayi City, Taiwan
Chia-Yi Christian Hospital, Chiayi City, Taiwan
National Taiwan University Hospital, Yun-Lin branch, Douliu, Taiwan
E-da hospital, Kaohsiung, Taiwan
National Taiwan University Hospital, Taipei, Taiwan
... and 3 other locations.
LDT Combined With TDF to Improve EGFR Decreasing in Patients With Chronic Hepatitis B Treated With TDF
Status: Recruiting
Last Changed: Nov 25, 2020
First Received: Nov 25, 2020
Disease(s): Chronic Hepatitis B
Locations: Ermei Li, Guangzhou, Guangdong, China
Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients
Status: Recruiting
Last Changed: Oct 08, 2020
First Received: Jan 06, 2017
Disease(s): Chronic Hepatitis
Intervention(s): Group A, TDF, Group B:TDF then TDF and Peginterferon alfa-2a, Group C:TDF and Peginterferon alfa-2a then TDF
Locations: Xixi Hospital of Hangzhou, Hangzhou, China
Changhai Hospital, Shanghai, China
Hua shan Hospital,Fudan University, Shanghai, China
Infectious diesease hospital of Huangpu district in Shanghai, Shanghai, China
No.9 hospital of shanghai, Shanghai, China
... and 4 other locations.
Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B
Status: Not yet recruiting
Last Changed: Nov 16, 2020
First Received: Nov 16, 2020
Disease(s): Chronic Hepatitis B
Intervention(s): NCO-48 Fumarate 4 mg, NCO-48 Fumarate 20 mg, Tenofovir Alafenamide 25 mg
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus
Status: Recruiting
Last Changed: Nov 25, 2020
First Received: Sep 02, 2020
Disease(s): Hepatitis D, Chronic
Intervention(s): JNJ-73763989, Placebo, Entecavir (ETV) monohydrate, Tenofovir disoproxil, Tenofovir alafenamide (TAF)
Locations: Ruane Clinical Research Group Inc, Los Angeles, California, United States
Stanford University School of Medicine, Redwood City, California, United States
Southern California GI and Liver Center, San Clemente, California, United States
Johns Hopkins University School of Medicine, Lutherville, Maryland, United States
Harvard Medical School - Massachusetts General Hospital, Boston, Massachusetts, United States
... and 59 other locations.